NCT00676871 2008-09-05A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Continuous Intravenous Infusion of MEDI-538 in Adults With B-Cell Chronic Lymphocytic Leukemia (CLL)MedImmune LLCPhase 1/2 Withdrawn30 enrolled